| 1 |
Gilani N, Arabi Belaghi R, Aftabi Y, Faramarzi E, Edgünlü T, Somi MH. Identifying Potential miRNA Biomarkers for Gastric Cancer Diagnosis Using Machine Learning Variable Selection Approach. Front Genet 2021;12:779455. [PMID: 35082831 DOI: 10.3389/fgene.2021.779455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Lin YT, Chiang CJ, Yang YW, Huang SP, You SL. Secular decreasing trends in gastric cancer incidence in Taiwan: A population-based cancer registry study. World J Gastroenterol 2021; 27(34): 5764-5774 [PMID: 34629800 DOI: 10.3748/wjg.v27.i34.5764] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Baek SM, Kim N, Kwon YJ, Lee HS, Kim HY, Lee J, Yoon H, Shin CM, Park YS, Lee DH. Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea. Gut Liver 2020;14:439-49. [PMID: 31533397 DOI: 10.5009/gnl19091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 4 |
Desai M, Boregowda U, Srinivasan S, Kohli DR, Al Awadhi S, Murino A, Yu LHK, Dinis-Ribeiro DM, Sharma P. Narrow band imaging for detection of gastric intestinal metaplasia and dysplasia: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36:2038-46. [PMID: 34090306 DOI: 10.1111/jgh.15564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Kim KW, Kim N, Choi Y, Kim WS, Yoon H, Shin CM, Park YS, Lee DH, Park YS, Ahn SH, Park DJ, Kim HH, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study. Gastric Cancer 2021;24:844-57. [PMID: 33598811 DOI: 10.1007/s10120-021-01163-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 6 |
Tang D, Ni M, Zhu H, Cao J, Zhou L, Shen S, Peng C, Lv Y, Xu G, Wang L, Zou X. Differential prognostic implications of gastric adenocarcinoma based on Lauren's classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study. Ann Transl Med 2021;9:646. [PMID: 33987344 DOI: 10.21037/atm-20-7953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Lindblad A, Kaucher S, Jaehn P, Kajüter H, Holleczek B, Lissner L, Becher H, Winkler V. The Incidence of Intestinal Gastric Cancer among Resettlers in Germany-Do Resettlers Remain at an Elevated Risk in Comparison to the General Population? Int J Environ Res Public Health 2020;17:E9215. [PMID: 33317154 DOI: 10.3390/ijerph17249215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Nissar B, Shah IA, ul Afshan F, Ganai BA. A decade in unravelling the etiology of gastric carcinogenesis in Kashmir, India – A high risk region. Gene Reports 2020;21:100832. [DOI: 10.1016/j.genrep.2020.100832] [Reference Citation Analysis]
|
| 9 |
Moreira AM, Pereira J, Melo S, Fernandes MS, Carneiro P, Seruca R, Figueiredo J. The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression. Cells 2020;9:E394. [PMID: 32046329 DOI: 10.3390/cells9020394] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 10 |
Qian Y, Wu X, Wang H, Hou G, Han X, Song W. PAK1 silencing is synthetic lethal with CDK4/6 inhibition in gastric cancer cells via regulating PDK1 expression. Hum Cell 2020;33:377-85. [PMID: 31919718 DOI: 10.1007/s13577-019-00317-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Hu K, Wang S, Wang Z, Li L, Huang Z, Yu W, Chen Z, Wu QF. Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China. BMJ Open 2019;9:e030639. [PMID: 31542754 DOI: 10.1136/bmjopen-2019-030639] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 12 |
Mesic A, Rogar M, Hudler P, Bilalovic N, Eminovic I, Komel R. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development. BMC Cancer 2019;19:919. [PMID: 31521144 DOI: 10.1186/s12885-019-6133-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 13 |
Rossi T, Tedaldi G, Petracci E, Abou Khouzam R, Ranzani GN, Morgagni P, Saragoni L, Monti M, Calistri D, Ulivi P, Molinari C. E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer. Int J Mol Sci 2019;20:E4452. [PMID: 31509966 DOI: 10.3390/ijms20184452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 14 |
Yan W, Gu L, Ren W, Ma X, Qin M, Lyu M, Wang S. Recognition of Helicobacter pylori by protein-targeting aptamers. Helicobacter 2019;24:e12577. [PMID: 30950149 DOI: 10.1111/hel.12577] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 15 |
Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int J Clin Oncol 2019;24:771-8. [PMID: 30980196 DOI: 10.1007/s10147-019-01443-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 16 |
Fukamachi H, Kim SK, Koh J, Lee HS, Sasaki Y, Yamashita K, Nishikawaji T, Shimada S, Akiyama Y, Byeon SJ, Bae DH, Okuno K, Nakagawa M, Tanioka T, Inokuchi M, Kawachi H, Tsuchiya K, Kojima K, Tokino T, Eishi Y, Kim YS, Kim WH, Yuasa Y, Tanaka S. A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors. J Exp Clin Cancer Res 2019;38:127. [PMID: 30866995 DOI: 10.1186/s13046-019-1121-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 17 |
Gantuya B, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Uchida T, Yamaoka Y. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. Gastric Cancer 2019;22:104-12. [PMID: 29934751 DOI: 10.1007/s10120-018-0844-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Furuya TK, Jacob CE, Tomitão MTP, Camacho LCC, Ramos MFKP, Eluf-Neto J, Alves VAF, Zilberstein B, Cecconello I, Ribeiro U Jr, Chammas R. Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer. Genes (Basel) 2018;9. [PMID: 30551681 DOI: 10.3390/genes9120631] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 19 |
Gu L, Yan W, Liu S, Ren W, Lyu M, Wang S. Trypsin enhances aptamer screening: A novel method for targeting proteins. Anal Biochem 2018;561-562:89-95. [PMID: 30196049 DOI: 10.1016/j.ab.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 20 |
Zhang R, Strong MJ, Baddoo M, Lin Z, Wang YP, Flemington EK, Liu YZ. Interaction of Epstein-Barr virus genes with human gastric carcinoma transcriptome. Oncotarget 2017;8:38399-412. [PMID: 28415594 DOI: 10.18632/oncotarget.16417] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 21 |
Matsuhashi N, Yoshida K, Yamaguchi K, Tanahashi T. Molecular Diagnosis and Targeted Therapy for Gastric Cancer. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy 2018. [DOI: 10.1007/978-981-10-6469-2_4] [Reference Citation Analysis]
|
| 22 |
Binato R, Santos EC, Boroni M, Demachki S, Assumpção P, Abdelhay E. A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis. Oncotarget 2018;9:7359-71. [PMID: 29484116 DOI: 10.18632/oncotarget.23670] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 23 |
Mesic A, Markocic E, Rogar M, Juvan R, Hudler P, Komel R. Single nucleotide polymorphisms rs911160 in AURKA and rs2289590 in AURKB mitotic checkpoint genes contribute to gastric cancer susceptibility: Mitotic Checkpoint Genes and Gastric Cancer Risk. Environ Mol Mutagen 2017;58:701-11. [DOI: 10.1002/em.22129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 24 |
Sánchez-Zauco N, Torres J, Gómez A, Camorlinga-Ponce M, Muñoz-Pérez L, Herrera-Goepfert R, Medrano-Guzmán R, Giono-Cerezo S, Maldonado-Bernal C. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study. BMC Cancer 2017;17:384. [PMID: 28558708 DOI: 10.1186/s12885-017-3310-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 25 |
Zhang C, Min L, Liu J, Tian W, Han Y, Qu L, Shou C. Integrated analysis identified an intestinal-like and a diffuse-like gene sets that predict gastric cancer outcome. Tumour Biol 2016. [PMID: 27858295 DOI: 10.1007/s13277-016-5454-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 26 |
Aguda BD, del Rosario RC, Chan MW. Oncogene-tumor suppressor gene feedback interactions and their control. Math Biosci Eng. 2015;12:1277-1288. [PMID: 26775863 DOI: 10.3934/mbe.2015.12.1277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 27 |
Yepes S, López R, Andrade RE, Rodriguez-Urrego PA, López-Kleine L, Torres MM. Co-expressed miRNAs in gastric adenocarcinoma. Genomics 2016;108:93-101. [PMID: 27422560 DOI: 10.1016/j.ygeno.2016.07.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 28 |
Alpízar-Alpízar W, Laerum OD, Christensen IJ, Ovrebo K, Skarstein A, Høyer-Hansen G, Ploug M, Illemann M. Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma. J Histochem Cytochem 2016;64:483-94. [PMID: 27370797 DOI: 10.1369/0022155416656173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 29 |
Cong H, Yao RY, Sun ZQ, Qiu WS, Yao YS, Feng TT, Xin C, Liang J, Yue LU. DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer. Oncol Lett 2016;11:842-8. [PMID: 26870294 DOI: 10.3892/ol.2015.3937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 30 |
Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014;55:621-628. [PMID: 25630323 DOI: 10.11622/smedj.2014174] [Cited by in Crossref: 191] [Cited by in F6Publishing: 222] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 31 |
Ieni A, Barresi V, Rigoli L, Caruso RA, Tuccari G. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach. Dis Markers 2015;2015:234851. [PMID: 26494937 DOI: 10.1155/2015/234851] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 32 |
Sandoval-Bórquez A, Saavedra K, Carrasco-Avino G, Garcia-Bloj B, Fry J, Wichmann I, Corvalán AH. Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers. Dis Markers 2015;2015:503762. [PMID: 26379360 DOI: 10.1155/2015/503762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 33 |
Oue N, Sentani K, Sakamoto N, Yasui W. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype. Cancer Sci. 2015;106:951-958. [PMID: 26033320 DOI: 10.1111/cas.12706] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 34 |
Jing JJ, Sun LP, Xu Q, Yuan Y. Effect of ERCC8 tagSNPs and their association with H. pylori infection, smoking, and alcohol consumption on gastric cancer and atrophic gastritis risk. Tumour Biol 2015;36:9525-35. [PMID: 26130415 DOI: 10.1007/s13277-015-3703-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 35 |
Cito L, Indovina P, Forte IM, Pentimalli F, Di Marzo D, Somma P, Barone D, Penon A, Penon D, Ceccherini E, Micheli P, Saragoni L, Di Domenico M, Feola A, Roviello F, Mattioli E, Giordano GG, Giordano A. pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer. J Cell Physiol 2015;230:802-5. [PMID: 25205458 DOI: 10.1002/jcp.24805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 36 |
Kim BC, Jeong HO, Park D, Kim CH, Lee EK, Kim DH, Im E, Kim ND, Lee S, Yu BP, Bhak J, Chung HY. Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects. Cancer Inform 2015;14:47-54. [PMID: 25983541 DOI: 10.4137/CIN.S16912] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 37 |
Jácome AA, Sankarankutty AK, dos Santos JS. Adjuvant therapy for gastric cancer: What have we learned since INT0116? World J Gastroenterol 2015; 21(13): 3850-3859 [PMID: 25852269 DOI: 10.3748/wjg.v21.i13.3850] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 38 |
Zhang X, Ni Z, Duan Z, Xin Z, Wang H, Tan J, Wang G, Li F. Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis. PLoS One 2015;10:e0116979. [PMID: 25646628 DOI: 10.1371/journal.pone.0116979] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 39 |
Böger C, Warneke VS, Behrens HM, Kalthoff H, Goodman SL, Becker T, Röcken C. Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer. Gastric Cancer 2015;18:784-95. [PMID: 25315085 DOI: 10.1007/s10120-014-0435-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 40 |
Masuyama H, Yoshitake N, Sasai T, Nakamura T, Masuyama A, Zuiki T, Kurashina K, Mieda M, Sunada K, Yamamoto H, Togashi K, Terano A, Hiraishi H. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion 2015;91:30-6. [PMID: 25632914 DOI: 10.1159/000368807] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 41 |
Shen X, Si Y, Yang Z, Wang Q, Yuan J, Zhang X. MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1. Med Oncol. 2015;32:361. [PMID: 25432696 DOI: 10.1007/s12032-014-0361-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 42 |
Effenberger M, Steinle H, Offner FA, Vogel W, Millonig G. Holes in gastric mucosa in upper gastrointestinal endoscopy. Eur J Gastroenterol Hepatol 2014;26:676-8. [PMID: 24743500 DOI: 10.1097/MEG.0000000000000050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 43 |
Palacio-Rúa KA, Isaza-Jiménez LF, Ahumada-Rodríguez E, Muñetón-Peña CM. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer. Rev Gastroenterol Mex 2014;79:79-89. [PMID: 24861525 DOI: 10.1016/j.rgmx.2014.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value. World J Gastroenterol 2014; 20(19): 5679-5684 [PMID: 24914328 DOI: 10.3748/wjg.v20.i19.5679] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 113] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 45 |
Yang M, Zhao Q, Wang X, Liu T, Yao G, Lou C, Zhang Y. TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma. Histopathology 2014;65:517-26. [PMID: 24621012 DOI: 10.1111/his.12413] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 46 |
Lee YS, Cho YS, Lee GK, Lee S, Kim YW, Jho S, Kim HM, Hong SH, Hwang JA, Kim SY. Genomic profile analysis of diffuse-type gastric cancers. Genome Biol. 2014;15:R55. [PMID: 24690483 DOI: 10.1186/gb-2014-15-4-r55] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 47 |
Palacio-rúa K, Isaza-jiménez L, Ahumada-rodríguez E, Ceballos-garcía H, Muñetón-peña C. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer. Revista de Gastroenterología de México (English Edition) 2014;79:79-89. [DOI: 10.1016/j.rgmxen.2014.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 48 |
Wang C, Huang XY, Yao JG, Huang BC, Huang CH, Liao P, Long XD. XRCC7 rs#7003908 Polymorphism and Helicobacter pylori Infection-Related Gastric Antrum Adenocarcinoma. Int J Genomics 2013;2013:124612. [PMID: 24319674 DOI: 10.1155/2013/124612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 49 |
Pinho SS, Carvalho S, Marcos-pinto R, Magalhães A, Oliveira C, Gu J, Dinis-ribeiro M, Carneiro F, Seruca R, Reis CA. Gastric cancer: adding glycosylation to the equation. Trends in Molecular Medicine 2013;19:664-76. [DOI: 10.1016/j.molmed.2013.07.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 50 |
Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M, Maiero S, Orzes E, Perin T, Zanussi S, De Paoli P, De Re V. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 2013;8:e77035. [PMID: 24204729 DOI: 10.1371/journal.pone.0077035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 51 |
Nemtsova MV, Bykov II, Udilova AA, Zaletaev DV, Khorobrykh TV. Allelic imbalance of 17p13.1 (TP53), 1p36.1 (RUNX3), and 16p22 (CDH1) loci and microsatellite instability in gastric cancer. Mol Biol 2013;47:727-32. [DOI: 10.1134/s0026893313050154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 52 |
Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445-1457. [PMID: 24009139 DOI: 10.1002/ijc.28470] [Cited by in Crossref: 96] [Cited by in F6Publishing: 108] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 53 |
Zhang X, Zhu H, Wu X, Wang M, Gu D, Gong W, Xu Z, Tan Y, Gong Y, Zhou J, Tang C, Tong N, Chen J, Zhang Z. A genetic polymorphism in TOX3 is associated with survival of gastric cancer in a Chinese population. PLoS One 2013;8:e72186. [PMID: 24069142 DOI: 10.1371/journal.pone.0072186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 54 |
Pohjanen VM, Koivurova OP, Mäkinen JM, Karhukorpi JM, Joensuu T, Koistinen PO, Valtonen JM, Niemelä SE, Karttunen RA, Karttunen TJ. Interleukin 6 gene polymorphism -174 is associated with the diffuse type gastric carcinoma. Genes Chromosomes Cancer 2013;52:976-82. [PMID: 23893709 DOI: 10.1002/gcc.22093] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 55 |
Stiekema J, Cats A, Kuijpers A, van Coevorden F, Boot H, Jansen EP, Verheij M, Balague Ponz O, Hauptmann M, van Sandick JW. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? Eur J Surg Oncol. 2013;39:686-693. [PMID: 23498364 DOI: 10.1016/j.ejso.2013.02.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 56 |
Qiu MZ, Cai MY, Zhang DS, Wang ZQ, Wang DS, Li YH, Xu RH. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med. 2013;11:58. [PMID: 23497313 DOI: 10.1186/1479-5876-11-58] [Cited by in Crossref: 91] [Cited by in F6Publishing: 110] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 57 |
Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF, Resnick MB. Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol 2013;304:G322-7. [PMID: 23238937 DOI: 10.1152/ajpgi.00263.2012] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 58 |
He Y, Zhao X, Gao J, Fan L, Yang G, Cho WC, Chen H. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci 2012;13:13764-80. [PMID: 23203033 DOI: 10.3390/ijms131113764] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 59 |
Ahn DH, Rah H, Choi YK, Jeon YJ, Min KT, Kwack K, Hong SP, Hwang SG, Kim NK. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog. 2013;52 Suppl 1:E39-E51. [PMID: 23001871 DOI: 10.1002/mc.21962] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 60 |
Duan Z, He C, Gong Y, Li P, Xu Q, Sun LP, Wang Z, Xing C, Yuan Y. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Gene. 2012;511:274-279. [PMID: 22982416 DOI: 10.1016/j.gene.2012.09.025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 61 |
Abadir A, Streutker C, Brezden-Masley C, Grin A, Kim YI. Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population. Clin Med Insights Gastroenterol 2012;5:43-50. [PMID: 24833933 DOI: 10.4137/CGast.S10070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 62 |
Leal MF, Calcagno DQ, Khayat AS, Silva TCR, Muniz JAPC, Assumpção PP, de Arruda Cardoso Smith M, Burbano RR. hTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates. Clin Exp Med 2013;13:221-4. [DOI: 10.1007/s10238-012-0195-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 63 |
Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, Park DJ, Kim HH, Jung HC. Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. J Gastroenterol Hepatol 2012;27:928-34. [PMID: 22142434 DOI: 10.1111/j.1440-1746.2011.07038.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 64 |
Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, Deguchi H, Enomoto S, Ueda K, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Tekeshita T, Mohara O, Ushijima T, Ichinose M. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer. 2012;131:2632-2642. [PMID: 22383377 DOI: 10.1002/ijc.27514] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 65 |
Moghanibashi M, Mohamadynejad P, Rasekhi M, Ghaderi A, Mohammadianpanah M. Polymorphism of estrogen response element in TFF1 gene promoter is associated with an increased susceptibility to gastric cancer. Gene 2012;492:100-3. [DOI: 10.1016/j.gene.2011.10.048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 66 |
Li Z, Chen J, Chan KW, Qiao L, Wong BC. A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Letters 2011;313:192-200. [DOI: 10.1016/j.canlet.2011.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 67 |
Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 68 |
Verbeke H, Geboes K, Van Damme J, Struyf S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta. 2012;1825:117-129. [PMID: 22079531 DOI: 10.1016/j.bbcan.2011.10.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 74] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 69 |
Förster S, Gretschel S, Jöns T, Yashiro M, Kemmner W. THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol 2011;24:1390-403. [PMID: 21701537 DOI: 10.1038/modpathol.2011.99] [Cited by in Crossref: 77] [Cited by in F6Publishing: 83] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 70 |
Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, Kubota K, Yamagata Y, Seto Y, Nakajima A, Goldenring JR, Kaminishi M, Nomura S. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology 2011;141:837-845.e1-7. [PMID: 21699780 DOI: 10.1053/j.gastro.2011.05.040] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 71 |
Alves MK, Ferrasi AC, Lima VP, Ferreira MV, de Moura Campos Pardini MI, Rabenhorst SH. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. Pathobiology. 2011;78:266-276. [PMID: 21849808 DOI: 10.1159/000329475] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 72 |
Tsang YH, Lamb A, Chen LF. New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection. J Cell Biochem 2011;112:381-6. [PMID: 21268057 DOI: 10.1002/jcb.22964] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 73 |
Giaginis C, Giagini A, Tsourouflis G, Gatzidou E, Agapitos E, Kouraklis G, Theocharis S. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. Dig Dis Sci 2011;56:777-85. [PMID: 20694513 DOI: 10.1007/s10620-010-1348-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 74 |
Chong PK, Lee H, Loh MC, Choong LY, Lin Q, So JB, Lim KH, Soo RA, Yong WP, Chan SP. Upregulation of plasma C9 protein in gastric cancer patients. Proteomics. 2010;10:3210-3221. [PMID: 20707004 DOI: 10.1002/pmic.201000127] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 75 |
Jang B, Kim WH. Molecular Pathology of Gastric Carcinoma. Pathobiology 2011;78:302-10. [DOI: 10.1159/000321703] [Cited by in Crossref: 80] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 76 |
Ryan JL, Jones RJ, Kenney SC, Rivenbark AG, Tang W, Knight ER, Coleman WB, Gulley ML. Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infect Agent Cancer 2010;5:27. [PMID: 21194482 DOI: 10.1186/1750-9378-5-27] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 77 |
Pollock CB, Rodriguez O, Martin PL, Albanese C, Li X, Kopelovich L, Glazer RI. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. PPAR Res. 2010;2010:571783. [PMID: 21318167 DOI: 10.1155/2010/571783] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 78 |
Kulka J, Szirtes I, Szász AM, Kupcsulik P, Kenessey I, Lotz G, Tímár J. [Pathology background of targeted therapy; quality control in pathology]. Magy Onkol 2010;54:343-50. [PMID: 21163765 DOI: 10.1556/MOnkol.54.2010.4.8] [Reference Citation Analysis]
|
| 79 |
Hong SJ, Jeon EJ, Oh JH, Seo EJ, Choi SW, Rhyu MG. The gene-reduction effect of chromosomal losses detected in gastric cancers. BMC Gastroenterol 2010;10:138. [PMID: 21092121 DOI: 10.1186/1471-230X-10-138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 80 |
Jagric T, Potrc S, Jagric T. Prediction of liver metastases after gastric cancer resection with the use of learning vector quantization neural networks. Dig Dis Sci 2010;55:3252-61. [PMID: 20186483 DOI: 10.1007/s10620-010-1155-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 81 |
Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci 2010;55:3124-31. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 82 |
Bae HI, Li Y, Na YK, Jung YW, Lee SM, Yang JS, Kim DS. Overexpression of the MUC2 gene through promoter hypomethylation in mucinous cell carcinomas and signet ring cell carcinomas of gastric cancer. Genes Genom 2010;32:429-35. [DOI: 10.1007/s13258-010-0051-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 83 |
Ju H, Lim B, Kim M, Noh SM, Kim WH, Ihm C, Choi BY, Kim YS, Kang C. SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility. Cancer 2010;116:4248-55. [PMID: 20549826 DOI: 10.1002/cncr.25213] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 84 |
Chen J, Lu Y, Zhang H, Ding Y, Ren C, Hua Z, Zhou Y, Deng B, Jin G, Hu Z, Xu Y, Shen H. A nonsynonymous polymorphism in IL23R gene is associated with risk of gastric cancer in a Chinese population. Mol Carcinog 2010;49:862-8. [PMID: 20607725 DOI: 10.1002/mc.20661] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 85 |
Diel IJ, Kurth AA, Seegenschmiedt H, Souchon R. Knochenmetastasen. Best Practice Onkologie 2010;5:4-16. [DOI: 10.1007/s11654-010-0249-6] [Reference Citation Analysis]
|
| 86 |
Ju H, Lim B, Kim M, Kim YS, Kim WH, Ihm C, Noh SM, Han DS, Yu HJ, Choi BY, Kang C. A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression. Neoplasia 2009;11:1340-7. [PMID: 20019842 DOI: 10.1593/neo.91132] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 87 |
Itadani H, Oshima H, Oshima M, Kotani H. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009;10:615. [PMID: 20015407 DOI: 10.1186/1471-2164-10-615] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 88 |
Hong SH, Choi JK, Ahn DH, Hong SP, Hwang SG, Kang H, Jeung M, Yim DJ, Cho YK, Kim NK. Association of theXRCC1 gene polymorphisms in patients with stomach cancer. Genes & Genomics 2009;31:435-441. [DOI: 10.1007/bf03191857] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 89 |
Florou D, Papadopoulos IN, Scorilas A. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun. 2010;391:214-218. [PMID: 19903463 DOI: 10.1016/j.bbrc.2009.11.034] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 90 |
Pinheiro C, Longatto-Filho A, Simões K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur J Cancer 2009;45:2418-24. [PMID: 19628385 DOI: 10.1016/j.ejca.2009.06.018] [Cited by in Crossref: 65] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 91 |
Tatemichi M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center Study Group. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta Oncol 2008;47:360-5. [PMID: 18347999 DOI: 10.1080/02841860701843035] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 92 |
Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945-1952. [PMID: 19531677 DOI: 10.1158/1055-9965.epi-09-0250] [Cited by in Crossref: 136] [Cited by in F6Publishing: 146] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 93 |
Xu WQ, Song LJ, Liu Q, Zhao L, Zheng L, Yan ZW, Fu GH. Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer. J Cancer Res Clin Oncol. 2009;135:1323-1330. [PMID: 19330352 DOI: 10.1007/s00432-009-0573-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 94 |
Elistratova EV, Laktionov PP, Shelestuk PI, Tuzikov SA, Vlassov VV, Rykova EY. Immunochemical and molecular-Genetic markers in diagnostics of gastric cancer. Biochem Moscow Suppl Ser B 2009;3:33-43. [DOI: 10.1134/s1990750809010041] [Reference Citation Analysis]
|
| 95 |
Mbulaiteye SM. Helicobacter Pylori associated global gastric cancer burden. Front Biosci 2009;Volume:1490. [DOI: 10.2741/3320] [Cited by in Crossref: 60] [Cited by in F6Publishing: 72] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 96 |
Yu XW, Dong NN, Gong YH, Xu Q, Yuan Y. In situ detection of Helicobacter pylori in gastric cancer and precancerous diseases and its significance. Shijie Huaren Xiaohua Zazhi 2008; 16(33): 3740-3745 [DOI: 10.11569/wcjd.v16.i33.3740] [Reference Citation Analysis]
|
| 97 |
Giaginis CT, Vgenopoulou S, Tsourouflis GS, Politi EN, Kouraklis GP, Theocharis SE. Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma. Pathol Oncol Res. 2009;15:173-181. [PMID: 18987997 DOI: 10.1007/s12253-008-9120-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 98 |
Bae SJ, Ahn DH, Hong SP, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J 2008;49:783-91. [PMID: 18972599 DOI: 10.3349/ymj.2008.49.5.783] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 99 |
Ohnuma S, Miura K, Horii A, Fujibuchi W, Kaneko N, Gotoh O, Nagasaki H, Mizoi T, Tsukamoto N, Kobayashi T, Kinouchi M, Okabe M, Sasaki H, Shiiba K, Miyagawa K, Sasaki I. Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues. Surgery 2009;145:57-68. [PMID: 19081476 DOI: 10.1016/j.surg.2008.08.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 100 |
Park MJ, Kim KH, Kim HY, Kim K, Cheong J. Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells. Carcinogenesis. 2008;29:2385-2393. [PMID: 18775915 DOI: 10.1093/carcin/bgn207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 101 |
Li YL, Tian Z, Fu BY. Changes of tumor suppressor gene PTEN and microsatellite instability in gastric cancer and precancerous lesion and their correlations. Shijie Huaren Xiaohua Zazhi 2008; 16(22): 2470-2475 [DOI: 10.11569/wcjd.v16.i22.2470] [Reference Citation Analysis]
|
| 102 |
Natalwala A, Spychal R, Tselepis C. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 2008; 14(24): 3792-3797 [PMID: 18609701 DOI: 10.3748/wjg.14.3792] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 90] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 103 |
Lee JH, Byun DS, Lee MG, Ryu BK, Kang MJ, Chae KS, Lee KY, Kim HJ, Park H, Chi SG. Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses. Int J Cancer 2008;122:1573-84. [PMID: 18059034 DOI: 10.1002/ijc.23166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 104 |
Shah MA, Kelsen DP. Gastric and Gastroesophageal Adenocarcinoma. The Molecular Basis of Cancer 2008. [DOI: 10.1016/b978-141603703-3.10042-1] [Reference Citation Analysis]
|
| 105 |
Vauhkonen H, Vauhkonen M, Sipponen P, Knuutila S. Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas. Cytogenet Genome Res 2007;119:39-45. [DOI: 10.1159/000109617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 106 |
Toyoda T, Tsukamoto T, Mizoshita T, Nishibe S, Deyama T, Takenaka Y, Hirano N, Tanaka H, Takasu S, Ban H, Kumagai T, Inada K, Utsunomiya H, Tatematsu M. Inhibitory effect of nordihydroguaiaretic acid, a plant lignan, on Helicobacter pylori-associated gastric carcinogenesis in Mongolian gerbils. Cancer Science 2007;98:1689-95. [DOI: 10.1111/j.1349-7006.2007.00599.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 107 |
Andersen LP. Colonization and infection by Helicobacter pylori in humans. Helicobacter 2007;12 Suppl 2:12-5. [PMID: 17991171 DOI: 10.1111/j.1523-5378.2007.00574.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 108 |
Malfertheiner P, Bornschein J. Magenkarzinom: Früherkennung und Prävention. Gastroenterologe 2007;2:330-338. [DOI: 10.1007/s11377-007-0108-3] [Reference Citation Analysis]
|
| 109 |
Leal MF, Lima EM, Silva PNO, Assumpção PP, Calcagno DQ, Payão SLM, Burbano RR, Smith MAC. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. World J Gastroenterol 2007; 13(18): 2568-2574 [PMID: 17552003 DOI: 10.3748/wjg.v13.i18.2568] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 110 |
Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61:2847-2851. [PMID: 11306456 DOI: 10.1002/path.2596] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 3.9] [Reference Citation Analysis]
|
